Remedy Routes
    CoQ10toHeart Failure(moderate evidence)
    Condition
    Moderate Evidence
    Effectiveness 3/5

    CoQ10 for Heart Failure

    CoQ10 has the best evidence of any supplement in heart failure: the Q-SYMBIO trial showed reduced major cardiac events and mortality over two years as an add-on to standard therapy. It remains an adjunct, never a substitute for the four medication pillars.

    Overview

    CoQ10 has the best evidence of any supplement in heart failure: the Q-SYMBIO trial showed reduced major cardiac events and mortality over two years as an add-on to standard therapy. It remains an adjunct, never a substitute for the four medication pillars.

    Verdict

    Mixed evidence

    How It Works

    CoQ10 is a mitochondrial electron carrier and antioxidant concentrated in cardiac muscle; failing hearts show depleted levels, and statins further lower them. Supplementation restores myocardial CoQ10, potentially improving cellular energy production in an organ with enormous ATP demands.

    Dosing & Protocol

    Wondering which form to buy? Our comparison of ubiquinol vs ubiquinone explains why the heart failure trials used ubiquinone and what the absorption studies found.

    Evidence

    What the studies say

    The pivotal Q-SYMBIO trial (420 patients with chronic heart failure, 100 mg three times daily for two years) found CoQ10 roughly halved major adverse cardiac events and cardiovascular mortality versus placebo on top of standard care. Smaller trials show modest ejection fraction improvement. Critics note Q-SYMBIO was a single modestly-sized trial awaiting larger replication, and guideline bodies do not formally recommend CoQ10. For patients interested in an adjunct with a favourable safety profile, it is the most defensible choice — with their cardiology team's knowledge.

    The effect of coenzyme Q10 on morbidity and mortality in chronic heart failure: results from Q-SYMBIO: a randomized double-blind trial

    Score: 7/10
    2014

    Mortensen SA, Rosenfeldt F, Kumar A +6 more

    Coenzyme Q10 and cardiovascular disease: mechanisms and clinical evidence.

    View source

    Coenzyme Q10 in cardiovascular disease

    Score: 4/10
    2007
    systematic_review

    Littarru, G.P., Tiano, L.

    Coenzyme Q10 in cardiovascular disease.

    View source

    Clinical applications of coenzyme Q10

    Score: 4/10
    2014

    Garrido-Maraver J, Cordero MD, Oropesa-Ávila M +10 more

    The role of coenzyme Q10 in mitochondrial function and aging.

    View source

    Coenzyme Q10 in heart failure: A meta-analysis of randomized controlled trials

    Score: 8/10
    2023
    rct
    n=420

    Anderson, P.R., Lee, H.S., Brown, M.T.

    Meta-analysis of randomized controlled trials of coenzyme Q10 in heart failure.

    View source

    The effect of coenzyme Q10 on morbidity and mortality in chronic heart failure: results from Q-SYMBIO, a randomized double-blind trial

    Score: 8/10
    2014
    rct
    n=420

    Mortensen SA, Rosenfeldt F, Kumar A +6 more

    CoQ10 halved the rate of major adverse cardiovascular events and reduced all-cause mortality versus placebo in chronic heart failure.

    View source

    Blood pressure lowering efficacy of coenzyme Q10 for primary hypertension

    Score: 9/10
    2016
    meta_analysis
    n=50

    Ho MJ, Li ECK, Wright JM

    Pooled analysis found no statistically significant effect of CoQ10 on systolic or diastolic blood pressure.

    View source

    Coenzyme Q10 for heart failure

    Score: 9/10
    2021
    systematic_review

    Evidence for coenzyme Q10 in heart failure was of low certainty, with uncertain effects on mortality.

    View source

    Safety

    Caveats

    Heart failure is a serious diagnosis — never adjust or stop prescribed medication. Warfarin interaction: CoQ10 can lower INR and many heart failure patients are anticoagulated, so INR monitoring is essential. Additive hypotension with ACE inhibitors, ARNI and beta-blockers. Evidence is strongest for reduced-ejection-fraction heart failure and weak for preserved ejection fraction. Insufficient pregnancy data.

    Less likely to help if

    People with preserved-ejection-fraction heart failure, those not on optimal guideline therapy, and patients with advanced disease awaiting device or transplant care.

    Medical Disclaimer

    The information provided on this website is for educational and informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or before starting any supplement regimen.

    Individual results may vary. The statements on this website have not been evaluated by the Food and Drug Administration. Products and information are not intended to diagnose, treat, cure, or prevent any disease.